Literature DB >> 35148487

Impact of SARS-COV2 Pandemic on Patients with Endometriosis and Their Health Care.

Inmaculada Nicolás1, María Ángeles Martínez-Zamora1, Meritxell Gracia1, Georgina Feixas1, Mariona Rius1, Francisco Carmona1.   

Abstract

Background: Endometriosis is a debilitating chronic inflammatory disease. The current SARS-COV2 pandemic has had an impact on the management of these patients. Tele-health care has been a relevant tool. The aim of this study was to analyze the impact of the SARS-COV2 pandemic on the perceived clinical health status and the type of care received in patients with endometriosis. Materials and
Methods: We evaluated 945 premenopausal women treated at the Hospital Clinic of Barcelona between October 1 and December 31, 2020. Five hundred forty-nine women had endometriosis, and 396 had other benign gynecological diseases. An online health survey was sent to these patients. Clinicopathological features data were recorded.
Results: Compared to patients with other benign gynecological diseases, a higher proportion of patients with endometriosis reported worsening of their symptoms (148/549, 27% vs. 85/396, 21.5%) and concern about their disease (515/549, 93.8% vs. 342/396, 86.4%), and more frequently received tele-health care (73.8% vs. 54.0%) during the pandemic. Patients with endometriosis and "significant" pelvic pain reported more concern and worsening than patients without "significant" pelvic pain, and evaluated the assistance received poorly. Multivariate analysis showed pelvic pain, limitation in usual activity, and sadness as risk factors of perception of disease worsening. Awaiting surgery and the feeling of sadness were risk factors of concern. Conclusions: Patients with endometriosis, and especially patients with "significant" pelvic pain, reported greater concern and the perception of worsening during the SARS-COV2 pandemic. Tele-health is a useful tool in patients with endometriosis, and face-to-face visit should be considered in those reporting "significant" pelvic pain. Clinical Trial Registration Number: HCB 1202011497.

Entities:  

Keywords:  SARS-COV2; endometriosis; pandemic; tele-health

Mesh:

Substances:

Year:  2022        PMID: 35148487     DOI: 10.1089/jwh.2021.0323

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  1 in total

1.  Determinants of Pain-Induced Disability in German Women with Endometriosis during the COVID-19 Pandemic.

Authors:  Roxana Schwab; Kathrin Stewen; Tanja Kottmann; Susanne Theis; Tania Elger; Bashar Haj Hamoud; Mona W Schmidt; Katharina Anic; Walburgis Brenner; Annette Hasenburg
Journal:  Int J Environ Res Public Health       Date:  2022-07-06       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.